Medical devices, healthcare technology and the business of care
510(k) clearance · K261134

Dormiva Anti-Snoring Mouth Guard

Koncept Innovators, Inc. · Decision date May 14, 2026

FDA DECISIONK261134

What did the FDA decide?

FDA records K261134 as a 510(k) premarket notification, with a decision dated May 14, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
May 14, 2026

FDA source record

Regulatory record facts

Identifier
K261134
Regulatory pathway
510(k) premarket notification
Product code
LRK
Decision code
SESE
Decision date
May 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, Anti-Snoring.

Product code
LRK
FDA device class
2

FDA decision timeline

  1. K261134 received

    Application receipt date recorded by FDA.

  2. K261134 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LRK

Product / regulatory recordCompanyPathwayDecision dateSource
Park Dental Research Corp.510(k) clearanceOct 20, 2026FDA
ForzaK260136
True Function Laboratory, Inc.510(k) clearanceOct 6, 2026FDA
Ram.Shaw Pte., Ltd.510(k) clearanceAug 27, 2026FDA
DnB Innovations, LLC510(k) clearanceJul 31, 2026FDA
VirtusK261366
Somnomed, Inc.510(k) clearanceJun 12, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Koncept Innovators, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Myrtle Beach, SC

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records